Development of a Continuous Glucose Monitoring Service by Clinical Pharmacists in a Medically Underserved Population.

Continuous glucose monitoring (CGM) is an evolving technology that provides a wealth of information to aid in managing diabetes. Professional CGM (ProCGM) is recommended when personal CGM is not desired or available. Patients in medically underserved areas may have limited access to personal CGM devices, thus ProCGM devices can be used for short-term monitoring and medication adjustment.

Evaluation of Student Peer- and Self-Grading in an Integrated Pharmacotherapy Course.

Objective: To determine if student peer- and self-grades correlate with faculty grades on case vignettes.

Methods: This study involved first professional-year students enrolled in an Integrated Pharmacotherapy course. The course included three modified team-based learning (TBL) activities (each consisting of individual and team readiness assurance tests, followed by three open-note case vignettes completed in teams).

Clinical inertia among health care providers in a public health safety-net clinic in the management of type 2 diabetes.

Background: Clinical inertia is defined as the lack of treatment intensification in patients who are not at evidence-based goals of therapy; it may be related to provider, patient, and health system-wide factors. Patient factors, including nonadherence and tablet burden, are further compounded by health and social disparities present in safety-net clinics. Clinical pharmacist-based interventions may impact provider or health system factors to reduce inertia in patients with poorly controlled diabetes.